Product Program year 2020 Source: CMS Open Payments

Crofab

Drug Anti-Venom

Open in the dashboard

General payments

$174,697

433 payments

Research payments

$0

0 payments

Through program year 2020, $174,697 in general payments and $0 in research payments were reported against Crofab (Anti-Venom).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $162,632 429
2019 General $12,065 4

Breakdown

Who paid General payments · program years 2019–2020
  1. BTG International, Inc. $174,697 433 payments
Top recipients General payments · program year 2020
  1. Spencer Greene Medical Toxicology · Kingwood, TX $26,679 16% · 35 payments
  2. William Banner Pediatric Critical Care Medicine · Oklahoma City, OK $25,210 16% · 29 payments
  3. Charles Gerardo Emergency Medicine · Durham, NC $22,774 14% · 15 payments
  4. University Of Alabama Hospital Teaching hospital · AL $20,000 12% · 1 payment
  5. Thomas Arnold Emergency Medicine · Shreveport, LA $11,497 7% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Emergency Medicine $58,407 43% · 100 practitioners
  2. Medical Toxicology Emergency Medicine $45,131 33% · 7 practitioners
  3. Pediatric Critical Care Medicine Pediatrics $25,210 18% · 1 practitioner
  4. Pediatric Emergency Medicine Pediatrics $2,672 2% · 3 practitioners
  5. Surgery $1,160 <1% · 2 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Oklahoma $51,725 32% · 43 recipients
  2. Texas $31,528 19% · 14 recipients
  3. North Carolina $25,389 16% · 9 recipients
  4. Colorado $14,000 9% · 2 recipients
  5. Louisiana $12,088 7% · 3 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

433 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record